Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-10-08Clinical Trial Update: Celecoxib in Managing Pain, Weight Loss, and Weakness in Patients With Advanced Cancer [NA]
A clinical trial evaluating celecoxib for pain, weight loss, and weakness in advanced cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-10-05Clinical Trial Update: Propofol Versus Propofol-Fentanyl as Sedation For Lumbar Puncture in Children With Acute Leukemia/Lymphoma [NA]
A completed trial comparing propofol alone versus propofol with fentanyl for sedation during lumbar puncture in children with acute leukemia…
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: Rituxan + BEAM and Auto Stem Cell Transplant for High Risk Lymphoma or Hodgkin's Disease [NA]
Clinical trial update for Rituxan with BEAM and autologous stem cell transplant in high-risk lymphoma or Hodgkin's disease; trial completed …
-
CLINICAL_TRIALS trial_result · 2015-09-28Clinical Trial Update: A Study of Oral Suberoylanilide Hydroxamic Acid (SAHA) in Patients With Malignant Lymphoma (0683-030) [Phase 1]
This update notes the completion of a Phase 1 trial evaluating oral SAHA (vorinostat) in patients with malignant lymphoma.
-
CLINICAL_TRIALS withdrawal · 2015-09-25Clinical Trial Update: Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma [Phase 1, Phase 2]
The clinical trial of lenalidomide for previously untreated advanced-stage follicular lymphoma has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-09-04Clinical Trial Update: Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) [Phase 3]
A Phase 3 trial comparing fluconazole to voriconazole for fungal infections in blood and marrow transplant patients has completed with resul…
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED) [Phase 1]
A completed Phase 1 safety study of ridaforolimus (MK-8669) in patients with advanced, refractory or recurrent malignancies, including lymph…
-
CLINICAL_TRIALS research · 2015-08-27Clinical Trial Update: Concurrent School Attendance And Cancer Therapy: The Experiences of 6-12 Year Old Pediatric Oncology Patients
This clinical trial update describes the experiences of 6- to 12-year-old pediatric cancer patients balancing school attendance with ongoing…
-
CLINICAL_TRIALS trial_result · 2015-08-27Clinical Trial Update: Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED) [Phase 1]
Phase 1 safety study of AP23573 (deforolimus) in patients with advanced, refractory, or recurrent malignancies has completed, including lymp…
-
CLINICAL_TRIALS trial_result · 2015-08-24Clinical Trial Update: Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer [Phase 2]
Phase 2 trial evaluating a conditioning regimen of fludarabine, cyclophosphamide, and total-body irradiation for patients undergoing donor b…
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: Study of XL228 Administered Intravenously to Subjects With Advanced Malignancies [Phase 1]
A Phase 1 study evaluating XL228 given intravenously in patients with advanced malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-21Clinical Trial Update: A Study of XL844 Administered as a Single Agent and in Combination With Gemcitabine in Adults With Advanced Malignancies [Phase 1]
Phase 1 study of XL844 alone and in combination with gemcitabine in adults with advanced cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Study of AP23573 in Patients With Relapsed or Refractory Hematologic Malignancies (8669-024)(COMPLETED) [Phase 2]
Completed Phase 2 study of AP23573 (ridaforolimus) in patients with relapsed or refractory hematologic malignancies, including leukemia, mye…
-
CLINICAL_TRIALS trial_result · 2015-08-19Clinical Trial Update: Global Phase1 Study to Assess the Safety and Tolerability of AZD1208 in Advanced Solid Tumors and Malignant Lymphoma [Phase 1]
Global Phase 1 study to assess the safety and tolerability of AZD1208 in patients with advanced solid tumors and malignant lymphoma; the stu…
-
CLINICAL_TRIALS withdrawal · 2015-08-19Clinical Trial Update: Combination Chemotherapy Plus Interferon Alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma [Phase 2]
A Phase 2 trial evaluating combination chemotherapy plus either interferon alfa or rituximab for Stage III/IV lymphoma has been withdrawn.
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor
Analysis of EBMT registry data evaluates off-label use of plerixafor in hematopoietic cell transplantation, summarizing indications and obse…
-
CLINICAL_TRIALS research · 2015-08-13Clinical Trial Update: Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia
A clinical trial update describing studies on the immunological repertoire in patients with lymphoma and chronic lymphocytic leukemia.
-
CLINICAL_TRIALS trial_result · 2015-08-10Clinical Trial Update: Prevalence of Lymphoma in IBD
This completed clinical trial assessed the prevalence of lymphoma among individuals with inflammatory bowel disease.
-
CLINICAL_TRIALS other · 2015-07-28Clinical Trial Update: Italian Platelet Technology Assessment Study [Phase 3]
The Phase 3 Italian Platelet Technology Assessment Study, sponsored by Centro Nazionale Sangue, evaluating Leukemia and Lymphoma indications…
-
CLINICAL_TRIALS trial_result · 2015-07-16Clinical Trial Update: Vorinostat After Stem Cell Transplant in Treating Patients With High-Risk Lymphoma [Phase 1]
Phase 1 trial evaluating vorinostat after stem cell transplant in patients with high-risk lymphoma; the study is completed and results were …
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: Immune Reconstitution in Oncology Patients Following Autologous Stem Cell Transplant
This clinical trial update reports on immune reconstitution in oncology patients following autologous stem cell transplantation.
-
CLINICAL_TRIALS trial_result · 2015-07-08Clinical Trial Update: Study of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma [Phase 1]
A Phase 1 study of oral PXD101 in patients with advanced solid tumors or lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma [Phase 2]
A Phase 2 trial evaluating MGCD0103 (mocetinostat) given three times weekly in patients with relapsed and refractory lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2015-06-18Clinical Trial Update: Phase I and Pharmacology Study of Camptothecin-20-O-Propionate Hydrate (CZ48) in Patients With Solid Tumors or Lymphoma [Phase 1]
Phase I pharmacology study evaluating camptothecin-20-O-propionate hydrate (CZ48) in patients with advanced solid tumors or lymphomas; the t…
-
CLINICAL_TRIALS withdrawal · 2015-06-16Clinical Trial Update: Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas [Phase 1]
The Phase 1 trial evaluating a single dose of intravenous recombinant human TNF-α with liposomal doxorubicin in patients with advanced solid…